Blue Medical CFO and CTO Ronald Horvers said, "His results-oriented approach, entrepreneurial spirit and business acumen will play a pivotal role in extending our track record of innovation, while helping us grow profitability and take full advantage of the global market opportunities ahead."

Blue Medical CEO Noel Coopmans said with products registered in over 25 countries and the introduction of the new drug eluting technology, the company has a fascinating growth potential.

"I see a bright future for Blue Medical, targeting a doubling of turnover in the next 2 years," Horvers added.

"I am eager to be part of the experienced and dedicated Blue Medical team and the challenges ahead."